Cushing's Disease
Cushing's disease is a rare condition caused by an overproduction of cortisol, often due to a tumor in the pituitary gland. Symptoms may include weight gain, high blood pressure, and changes in mood.
Cushing’s Disease: Lu AG13909 Treatment Study
We are investigating a new medication, Lu AG13909, for adults with Cushing’s disease to see how it affects cortisol levels and its safety. This trial aims to improve understanding of this rare condition and its treatment options.
1-2 years>20 visitsEfficacy phase (II)Post-Trial Drug AccessNo PlaceboPartially RemoteInvestigational MedicinesInjectionEndocrinologyInternal Medicine
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you pregnant, breastfeeding, or planning to become pregnant?
- Do you have poorly controlled diabetes or high blood pressure?
- Have you had pituitary surgery in the last 3 months?
- Do you have a history of severe psychiatric illness?
- Are you currently taking any medications that could affect your health, like steroids or blood thinners?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ag13909
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centre Hospitalier Universitaire D'Angers
Endocrinology, Diabetology and Nutrition
Angers, France
Hospices Civils De Lyon
Endocrinology
Bron, France
Assistance Publique Hopitaux De Paris
Endocrinology and Reproductive diseases
Croulebarbe, France
Sponsor: H. Lundbeck A/S
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.